Sanofi — Insilico Medicine AI discovery collaboration (2022)
Sanofi contracted for Insilico's Pharma.AI platform to advance drug candidates. Its filing separates the received upfront payment from contingent milestone potential.
- Announced
- 8 Nov 2022 1
Contract facts
Source per value- DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
- 2022-11-081
- BuyerThe purchasing organisation or named customer.
- Sanofi1
- VendorThe contracting supplier or AI provider, as named in the source.
- Insilico Medicine1
- SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
- Enterprise
- Upfront payment $Upfront payment stated for research and licence collaborations.
- $12,500,0001
- Potential milestones $Contingent milestone payments stated for the collaboration, paid only if targets are reached.
- $1,200,000,0001
- Product or programThe AI product, model, platform or program supplied.
- Pharma.AI1
Sources
- sec.gov accessed 2026-11-11
Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.
Related contracts
All 87 contracts-
Roche and Genentech — Recursion AI drug discovery collaboration (2021)
Roche and Genentech · Recursion
Undisclosed -
Boehringer Ingelheim — IBM antibody discovery agreement (2023)
Boehringer Ingelheim · IBM
Undisclosed -
Eli Lilly — Isomorphic Labs AI discovery collaboration (2024)
Eli Lilly and Company · Isomorphic Labs
Undisclosed -
Novartis — Isomorphic Labs AI discovery collaboration (2024)
Novartis · Isomorphic Labs
Undisclosed -
Moderna — OpenAI enterprise collaboration (2024)
Moderna · OpenAI
Undisclosed
Spot a change?
Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.